China SXT Pharmaceuticals (SXTC) Inventory Average (2018 - 2025)
Historic Inventory Average for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $789699.5.
- China SXT Pharmaceuticals' Inventory Average fell 497.5% to $789699.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $789699.5, marking a year-over-year decrease of 497.5%. This contributed to the annual value of $811454.0 for FY2025, which is 2238.12% up from last year.
- Per China SXT Pharmaceuticals' latest filing, its Inventory Average stood at $789699.5 for Q3 2025, which was down 497.5% from $847643.0 recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Inventory Average ranged from a high of $927487.0 in Q1 2022 and a low of $512234.0 during Q3 2023
- In the last 5 years, China SXT Pharmaceuticals' Inventory Average had a median value of $826950.2 in 2022 and averaged $766677.8.
- Its Inventory Average has fluctuated over the past 5 years, first tumbled by 3774.93% in 2023, then soared by 6223.91% in 2024.
- Quarter analysis of 5 years shows China SXT Pharmaceuticals' Inventory Average stood at $848571.5 in 2021, then fell by 3.03% to $822856.5 in 2022, then crashed by 37.75% to $512234.0 in 2023, then skyrocketed by 62.24% to $831044.0 in 2024, then decreased by 4.98% to $789699.5 in 2025.
- Its Inventory Average was $789699.5 in Q3 2025, compared to $847643.0 in Q1 2025 and $831044.0 in Q3 2024.